Alejandro (Alex) Jadad | |
---|---|
Born | Medellin, Colombia | August 9, 1963
Nationality | Canadian and Colombian |
Alma mater | Pontificia Universidad Javeriana; University of Oxford |
Known for | Jadad Scale; Evidence-based medicine; Systematic reviews; Clinical trials; Bias; eHealth innovation; Collaborative decision-making; Computational Management |
Spouse | Martha Garcia (m. 1988) |
Children | 2 |
Scientific career | |
Fields | Future of Health and Medicine; Jadad Scale; Evidence-based medicine; Systematic reviews; Clinical trials; Bias detection and reduction; Pain relief; End-of-life care; Artificial intelligence; Machine learning; Medical innovation; Computational Management; Human-machine collaboration |
Institutions | University of Oxford; McMaster University; University Health Network; University of Toronto |
Doctoral advisor | Henry McQuay |
Other academic advisors | David Sackett; Iain Chalmers; Murray Enkin |
Alejandro R. Jadad Bechara (Alex Jadad; born August 9, 1963) is a Canadian-Colombian physician whose work focuses on improving health for all, and transforming healthcare, through creative human-machine collaboration powered by scientific evidence and collaboration across traditional boundaries. [1] [2] He is also known as the researcher responsible for the development of the Jadad Scale, the first validated tool to assess the methodological quality of clinical trials. He also co-created the methodology behind 'Computational Management', a systematic approach to facilitate task automation for the integration of artificial intelligence into existing workflows. [3]
Jadad was born in Medellín, and grew up in Montería, Colombia. When he was a medical student, he conducted the first studies on the jargon, the chemical composition and the clinical implications of a drug called 'basuco' in Colombia, which soon became known worldwide as "crack" cocaine. [4] He obtained his medical degree in 1986 at the Pontificia Universidad Javeriana in Bogota, where he also became a specialist in anesthesiology and intensive care. In 1989, he received a grant from the British Council, and became Clinical Research Fellow at the Oxford Pain Relief Pain Unit, University of Oxford, where he trained in pain management and end of life care, and conducted research that demonstrated that neuropathic pain ("pain in numb areas due to nerve damage") could be relieved by opioids. [5] This work led to the 1992 Overseas Research Student Award from the Committee of Vice-Chancellors and Principals of the Universities of the United Kingdom, and his enrolment as a doctoral student in Balliol College, the oldest school in the University of Oxford, where he received in 1994 the degree of Doctor of Philosophy (DPhil) in Clinical Medicine. His doctoral thesis, entitled "Meta-analysis of Controlled Trials on Pain Relief", [6] was published and widely disseminated by the British National Health Service (NHS). It guided the development of new tools to identify and distill health-related information, methods to handle big data to support health-related decisions, and the validation of the Jadad scale.
This was the first validated tool to assess the methodological quality of clinical trials in the world. As of 2022, it had been cited more than 23,000 times in the biomedical literature, being used to identify systematic differences among studies of the same healthcare interventions in more than 5,000 reviews of research in virtually all areas in the healthcare sector. [7] The scale includes three components which are directly related to the reduction of bias: randomization, blinding, and the description of dropouts and withdrawals. These are presented as 'yes' or 'no' questions and produces scores that range from 0 to 5. Studies that receive a score of 2 points or less has been shown to exaggerate the produce treatment effects that are 35% larger on average than those produced by the trials with 3 or more points. [8]
In 1995, Jadad joined McMaster University in Canada, where he stayed until 1999. During this period, he was Director of the Health Information Research Unit; [9] Co-director of the Canadian Cochrane Centre and Network, [10] Associate Medical Director of the Program in Evidence-based on Cancer Care Ontario, [11] and the Founding Director of the McMaster Evidence-based Practice Center [12] (the first of its kind funded by the US government overseas), and Professor in the Department of Clinical Epidemiology and Biostatistics. [13]
In 2000, Jadad moved to Toronto as the Inaugural Rose Family Chair in Supportive Care (a post he held until 2010), which enabled work on the reconceptualization of terms such as 'health' or a 'good death', as a means to guide the design, development, implementation and evaluation of innovations aimed at allowing people, even those living with complex chronic conditions or even terminal illnesses, to consider themselves to be healthy until the end. Simultaneously, he became the Founding Director of the Program in eHealth Innovation [14] and Professor in the Department of Anesthesia in the Faculty of Medicine, and in the Institute for Health Policy, Management and Evaluation at the University of Toronto. In this capacity, he led the creation of the Centre for Global eHealth Innovation, [14] a simulator of the future, to study and optimize the use of the information and communication technologies (ICTs) before their introduction into the health system. The construction of the centre was supported by the Canada Foundation for Innovation and the University Health Network, the largest hospital in Canada, where it is located. During this time, he also led the development of virtual clinical tools to transform the encounter between patients and health professionals, and new ways of using ICTs to respond to major threats to public health (e.g., obesity, complex chronic diseases and challenges at the end of life) and to allow the public (especially young people) to guide the creation of the future of the health system. To support this work, in 2002, Jadad was awarded the Canada Research Chair in eHealth Innovation (Tier 1), which he held until 2015. From 2016 to 2019, he was Director of the Institute for Global Health Equity and Innovation, University of Toronto.
In 1992, Jadad became the inaugural President of the Colombian Science and Technology Network in the UK, [15] which was part of the Caldas Network, supported by Colciencias, in order to connect the country's scientific diaspora, worldwide. [16]
In 1998, he authored the book with which the British Medical Journal celebrated the 50th anniversary of modern clinical trials. [17] A new edition, co-written with Murray Enkin, was published in 2007. [18]
In 2008, Jadad led a global conversation about the meaning of health, supported by the British Medical Journal. [19]
In 2010, he was the Editor-in-Chief of When people live with multiple chronic diseases: A collaborative approach to an emerging global challenge, one of the first books in medicine co-created globally using digital technologies. The same year, he chaired and convened the Global People-Centered eHealth Innovation Forum in the European Ministerial Conference; [20] the First International Youth-Led Innovation Forum to promote entrepreneurship among millennials and centennials [21] in Brussels and Extremadura; and the First International Summit on Family-Centered Health, supported by the government of China [22]
In 2019, he became a member of the Council of the Wise, a group of 43 experts in eight different areas charged by the government of Colombia to produce recommendations about the future of the country in the following 25 years. [23]
In 2021, he was selected as one of the members of the Public Health Leadership Coalition, a group assembled by the World Federation of Public Health Associations to foster evidence-informed decisions about the COVID-19 pandemic and other major existential health threats.
Jadad lives in Toronto with Martha Garcia, his wife, whom he started dating when he was 17. They have two daughters and two grandchildren.
Scopus Profile = Author ID: 35430539800
Chiropractic is a form of alternative medicine concerned with the diagnosis, treatment and prevention of mechanical disorders of the musculoskeletal system, especially of the spine. It is based on several pseudoscientific ideas.
Pain management is an aspect of medicine and health care involving relief of pain in various dimensions, from acute and simple to chronic and challenging. Most physicians and other health professionals provide some pain control in the normal course of their practice, and for the more complex instances of pain, they also call on additional help from a specific medical specialty devoted to pain, which is called pain medicine.
A transcutaneous electrical nerve stimulation is a device that produces mild electric current to stimulate the nerves for therapeutic purposes. TENS, by definition, covers the complete range of transcutaneously applied currents used for nerve excitation, but the term is often used with a more restrictive intent, namely, to describe the kind of pulses produced by portable stimulators used to reduce pain. The unit is usually connected to the skin using two or more electrodes which are typically conductive gel pads. A typical battery-operated TENS unit is able to modulate pulse width, frequency, and intensity. Generally, TENS is applied at high frequency (>50 Hz) with an intensity below motor contraction or low frequency (<10 Hz) with an intensity that produces motor contraction. More recently, many TENS units use a mixed frequency mode which alleviates tolerance to repeated use. Intensity of stimulation should be strong but comfortable with greater intensities, regardless of frequency, producing the greatest analgesia. While the use of TENS has proved effective in clinical studies, there is controversy over which conditions the device should be used to treat.
Prolotherapy, also called proliferation therapy, is an injection-based treatment used in chronic musculoskeletal conditions. It has been characterised as an alternative medicine practice.
A hierarchy of evidence, comprising levels of evidence (LOEs), that is, evidence levels (ELs), is a heuristic used to rank the relative strength of results obtained from experimental research, especially medical research. There is broad agreement on the relative strength of large-scale, epidemiological studies. More than 80 different hierarchies have been proposed for assessing medical evidence. The design of the study and the endpoints measured affect the strength of the evidence. In clinical research, the best evidence for treatment efficacy is mainly from meta-analyses of randomized controlled trials (RCTs). Systematic reviews of completed, high-quality randomized controlled trials – such as those published by the Cochrane Collaboration – rank the same as systematic review of completed high-quality observational studies in regard to the study of side effects. Evidence hierarchies are often applied in evidence-based practices and are integral to evidence-based medicine (EBM).
David Lawrence Sackett was an American-Canadian physician and a pioneer in evidence-based medicine. He is known as one of the fathers of Evidence-Based Medicine. He founded the first department of clinical epidemiology in Canada at McMaster University, and the Oxford Centre for Evidence-Based Medicine. He is well known for his textbooks Clinical Epidemiology and Evidence-Based Medicine.
Extracorporeal shockwave therapy (ESWT) is a treatment using powerful acoustic pulses which is mostly used to treat kidney stones and in physical therapy and orthopedics.
Chronic care management encompasses the oversight and education activities conducted by health care professionals to help patients with chronic diseases and health conditions such as diabetes, high blood pressure, systemic lupus erythematosus, multiple sclerosis, and sleep apnea learn to understand their condition and live successfully with it. This term is equivalent to disease management for chronic conditions. The work involves motivating patients to persist in necessary therapies and interventions and helping them to achieve an ongoing, reasonable quality of life.
Management of ME/CFS focuses on symptoms management, as no treatments that address the root cause of the illness are available. Pacing, or regulating one's activities to avoid triggering worse symptoms, is the most common management strategy for post-exertional malaise. Clinical management varies widely, with many patients receiving combinations of therapies.
The Jadad scale, sometimes known as Jadad scoring or the Oxford quality scoring system, is a procedure to assess the methodological quality of a clinical trial by objective criteria. It is named after Canadian-Colombian physician Alex Jadad who in 1996 described a system for allocating such trials a score of between zero and five (rigorous). It is the most widely used such assessment in the world, and as of May 2024, its seminal paper has been cited in over 24,500 scientific works.
The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.
Gender-biased diagnosing is the idea that medical and psychological diagnosis are influenced by the patient's gender. Several studies have found evidence of differential diagnosis for patients with similar ailments but of different sexes. Female patients face discrimination through the denial of treatment or miss-classification of diagnosis as a result of not being taken seriously due to stereotypes and gender bias. According to traditional medical studies, most of these medical studies were done on men thus overlooking many issues that were related to women's health. This topic alone sparked controversy and questions about the medical standard of our time. Popular media has illuminated the issue of gender bias in recent years. Research that was done on diseases that affected women more were less funded than those diseases that affected men and women equally.
Joseph Antony Cafazzo is a Canadian biomedical engineer, educator, and researcher.
Beth Darnall is American scientist, pain psychologist, author, and Associate Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University School of Medicine where she directs the Stanford Pain Relief Innovations Lab. From 2005 to 2012, Darnall was an assistant professor and associate professor at Oregon Health & Science University.
Murray W. Enkin was a Canadian physician and writer. He was born in Toronto, Ontario, and studied medicine at the University of Toronto and later specialized as an obstetrician and gynaecologist at Long Island College Hospital in Brooklyn. He was a professor, philosopher, activist, public speaker and author, who contributed to the fields of maternal care and childbirth, and evidence-based medicine.
Robert D. Kerns is an American clinical psychologist, academic and author. He is Professor Emeritus of Psychiatry, Neurology and Psychology at Yale University and Senior Research Scientist of Psychiatry at the Yale School of Medicine. He is also a Program Director of National Institutes of Health, Department of Defense and Department of Veterans Affairs Pain Management Collaboratory Coordinating Center.
Robert Brian Haynes OC is a Canadian physician, clinical epidemiologist, researcher and an academic. He is professor emeritus at McMaster University and one of the founders of evidence-based medicine.
Paul Edward Rolan is an Australian physician, medical researcher, academic, and public health advocate. He specializes in the management of chronic pain and headache, and development of novel treatments.
Mindfulness-Oriented Recovery Enhancement (MORE) is an evidence-based mind-body therapy program developed by Eric Garland. It is a therapeutic approach grounded in affective neuroscience that combines mindfulness training with reappraisal and savoring skills. Garland developed this approach by combining the key features of mindfulness training, "Third Wave" cognitive-behavioral therapy, and principles from positive psychology.